Page last updated: 2024-08-22

vasotocin and FR900359

vasotocin has been researched along with FR900359 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bennett, PR; Blanks, AM; Hanyaloglu, AC; Kim, SH; MacIntyre, DA; Terzidou, V; Thornton, S	1

Other Studies

1 other study(ies) available for vasotocin and FR900359

Article	Year
The oxytocin receptor antagonist, Atosiban, activates pro-inflammatory pathways in human amnion via G(αi) signalling. Molecular and cellular endocrinology, 2016, Jan-15, Volume: 420 Topics: Amnion; Cyclooxygenase 2; Depsipeptides; Female; Gene Expression Regulation; Gene Knockdown Techniques; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Inflammation Mediators; MAP Kinase Signaling System; NF-kappa B; Oxytocin; Pertussis Toxin; Phospholipases A2; Pregnancy; Receptors, Oxytocin; Signal Transduction; Vasotocin	2016

Article

Year

The oxytocin receptor antagonist, Atosiban, activates pro-inflammatory pathways in human amnion via G(αi) signalling.

Molecular and cellular endocrinology, 2016, Jan-15, Volume: 420

Topics: Amnion; Cyclooxygenase 2; Depsipeptides; Female; Gene Expression Regulation; Gene Knockdown Techniques; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Inflammation Mediators; MAP Kinase Signaling System; NF-kappa B; Oxytocin; Pertussis Toxin; Phospholipases A2; Pregnancy; Receptors, Oxytocin; Signal Transduction; Vasotocin

2016